Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fulcrum Therapeutics (FULC) Return on Assets (2020 - 2025)

Historic Return on Assets for Fulcrum Therapeutics (FULC) over the last 6 years, with Q3 2025 value amounting to 0.24%.

  • Fulcrum Therapeutics' Return on Assets fell 1800.0% to 0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24%, marking a year-over-year decrease of 1800.0%. This contributed to the annual value of 0.04% for FY2024, which is 3600.0% up from last year.
  • Per Fulcrum Therapeutics' latest filing, its Return on Assets stood at 0.24% for Q3 2025, which was down 1800.0% from 0.24% recorded in Q2 2025.
  • Over the past 5 years, Fulcrum Therapeutics' Return on Assets peaked at 0.07% during Q1 2025, and registered a low of 0.5% during Q2 2022.
  • Its 5-year average for Return on Assets is 0.31%, with a median of 0.36% in 2023.
  • Its Return on Assets has fluctuated over the past 5 years, first plummeted by -3100bps in 2021, then skyrocketed by 4700bps in 2025.
  • Over the past 5 years, Fulcrum Therapeutics' Return on Assets (Quarter) stood at 0.33% in 2021, then crashed by -40bps to 0.46% in 2022, then rose by 22bps to 0.36% in 2023, then surged by 90bps to 0.04% in 2024, then plummeted by -569bps to 0.24% in 2025.
  • Its Return on Assets was 0.24% in Q3 2025, compared to 0.24% in Q2 2025 and 0.07% in Q1 2025.